Gastric electrical stimulation decreases gastric distension-induced central nociception response through direct action on primary afferents

PLoS One. 2012;7(12):e47849. doi: 10.1371/journal.pone.0047849. Epub 2012 Dec 20.

Abstract

Background & aims: Gastric electrical stimulation (GES) is an effective therapy to treat patients with chronic dyspepsia refractory to medical management. However, its mechanisms of action remain poorly understood.

Methods: Gastric pain was induced by performing gastric distension (GD) in anesthetized rats. Pain response was monitored by measuring the pseudo-affective reflex (e.g., blood pressure variation), while neuronal activation was determined using c-fos immunochemistry in the central nervous system. Involvement of primary afferents was assessed by measuring phosphorylation of ERK1/2 in dorsal root ganglia.

Results: GES decreased blood pressure variation induced by GD, and prevented GD-induced neuronal activation in the dorsal horn of the spinal cord (T9-T10), the nucleus of the solitary tract and in CRF neurons of the hypothalamic paraventricular nucleus. This effect remained unaltered within the spinal cord when sectioning the medulla at the T5 level. Furthermore, GES prevented GD-induced phosphorylation of ERK1/2 in dorsal root ganglia.

Conclusions: GES decreases GD-induced pain and/or discomfort likely through a direct modulation of gastric spinal afferents reducing central processing of visceral nociception.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Afferent Pathways*
  • Animals
  • Biomarkers / metabolism
  • Blood Pressure
  • Electric Stimulation Therapy*
  • Ganglia, Spinal / pathology
  • Ganglia, Spinal / physiopathology
  • Male
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Nociception / physiology*
  • Pain / complications
  • Paraventricular Hypothalamic Nucleus / pathology
  • Paraventricular Hypothalamic Nucleus / physiopathology
  • Phosphorylation
  • Posterior Horn Cells / metabolism
  • Proto-Oncogene Proteins c-fos / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Solitary Nucleus / pathology
  • Solitary Nucleus / physiopathology
  • Stomach Diseases / complications
  • Stomach Diseases / metabolism
  • Stomach Diseases / physiopathology*
  • Stomach Diseases / therapy*

Substances

  • Biomarkers
  • Proto-Oncogene Proteins c-fos
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3

Grants and funding

This work was supported by the University of Rouen, Institute for Research and Innovation in Biomedicine (IRIB), by the French Ministry of Health Grants for therapeutic innovation (STIC). WO was the recipient of a fellowship from the French Society of Gastroenterology (SNFGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.